Brian De, MD

Assistant Professor of CNS Radiation Oncology 🧠 ☢️ at @MDAndersonNews

[Brian De, MD @BrianDeMD]

📣 Exciting news! Thrilled to share that I have started at @MDAndersonNews as an Assistant Professor of Radiation Oncology ☢️, specializing in tumors of the brain and spine 🧠

Grateful for this opportunity to make a meaningful impact in patients' lives 🙏

[Marcus Florez @MarcusAFlorez]

Still feels unreal! I am so excited to have matched to @MDAndersonNews for #radonc ! What a journey it’s been to get here! I am so thankful for my incredible wife, my loving family, and all my amazing mentors that invested in me to help make this dream possible!

[Ethan Ludmir MD @ebludmir]

Thrilled to be presenting our randomized ph2 results on local therapy for oligometastatic #pancreascancer at #GI24 on 1/19.
@MDAndersonNews @ChadTangMD @AlexSherryMD @eugenekoay @ACKoongMDPhD @PrajnanDasMD
@drsmags @DrEmmaHolliday @DrShubhamPant
@DanZhaoMD

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

[Steven H. Lin @StevenLin_MDPhD]

Fascinating presentation from #radonc resident @MDAndersonNews @adam_grippin, travel award winner to #WCLC2023, on temporal relationship of PD-L1 induction and #CovidVaccines in lung cancer diagnostic biopsies. Therapeutic implication being explored!

[Journal of Neuro-Oncology @JNeurooncol]

A prospective study by @MartinTomMD and colleagues showed that PET/CT with 18F-fluciclovine, a repurposed widely available radiotracer, has promising ability to distinguish radiation necrosis from tumor progression after #radiosurgery.
Read more: https://t.co/6TDJK4VmWq

[Emma B. Holliday MD @DrEmmaHolliday]

Stellar @baylormed MS3 Marcus Flores presents on how the PRISM score stratifies outcomes for patients treated with SSRS @MDAndersonNews and Mayo. Important implications to individualize treatment for patients! Thanks for excellent mentorship @BrianDeMD!

[Marcus Florez @MarcusAFlorez]

Excited to share our work on the incidence of PEP changes in phase 3 clinical trials. I'm grateful for the opportunity to work on such an impactful project under the mentorship of @ebludmir and @JAbiJaoude. Thnx to the support of our team @MDAndersonNews https://t.co/Pr0BlV3xB7

[Ethan Ludmir MD @ebludmir]

@MarcusAFlorez @JAbiJaoude and team reporting on PEP changes after enrollment begins; policy rec - need COMPLETE protocol published w trials, including history of changes. @RKouzyMD @TaniguchiMD @cd_fuller @roshalp @michael_overman @BrianDeMD @mekupferman

[Lauren Andring @LaurenAndring]

Men with cT4 prostate ca have significant morbidity associated w/ local disease burden.

Definitive local therapy with☢️ or🔪 was associated w/ 📈 LRFS, DFS, CRFS, and OS, even in men with M1 disease!

https://t.co/erZi0idYNY

[Emma B. Holliday MD @DrEmmaHolliday]

There has been a lot of 🔥discussion lately of short course radiation (SCRT) for locally advanced rectal cancer (LARC).
I❤️SCRT bc it is convenient for working patients or those who travel for 🏥care. However, the RAPIDO update gives me pause. Let’s look at the history of SCRT:

[Cholangiocarcinoma Foundation @curecc]

Marion U. Schwartz Memorial Research Fellowship: Supported by CCF.

Ethan Ludmir, The University of Texas MD Anderson Cancer Center

Integrating Radiomics and Immunogenomics to Predict Tumor-Related Liver Failure for Patients with Metastatic Intrahepatic Cholangiocarcinoma.

[Chad Tang, MD @ChadTangMD]

Kids asleep,🧵time: EXTEND is randomized basket trial testing whether MDT improves PFS for oligometastatic cancers. The primary analysis for each histology-specific basket. Thanks to @JAMAOnc for reporting the prostate intermittent hormone basket here: https://t.co/XEKXqRee5D

[Brian De, MD @BrianDeMD]

@ggreen1986 Great question. Our practice has been to give LCT as true consolidation for OM-NSCLC, i.e., after upfront osi, to lesions that are visible on CT except sclerotic mets that are no longer FDG avid on PET. This may change in the coming yrs as the data evolve.

[Brian De, MD @BrianDeMD]

Pleased to share our work in JCO Precision Oncology examining molecular alterations among NSCLC patients with synchronous oligometastatic disease in this collaborative work from @MDAndersonNews, available as open access.

https://t.co/i1aVu5D8cp

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Packed house for the Ritsuko and James Cox Lectureship!Thank you @_APollack for your Grand Rounds lecture & for spending the day with our residents.This is a beautiful way to honor a giant in our field who was tirelessly committed to education. We miss him so much. @ACKoongMDPhD

[Nikhil Rammohan @Nikhil_Rm_MDPhD]

Delighted to share our most recent work investigating #aging after #WBRT, published in Neuro-0ncology @NeuroOnc. Free access link: https://t.co/KnIluyQJzc

[Todd Hollon @ToddCHollon]

We introduce #DeepGlioma, the first AI-based molecular classification system for diffuse gliomas. DeepGlioma was developed by @mlins_lab at @umichneuro with our incredible collaborators. Check out the paper in @NatureMedicine at https://t.co/dYGmuvjtYF.

[Emma B. Holliday MD @DrEmmaHolliday]

Had a great dinner tonight celebrating the achievements of these outstanding humans! So proud they are directing some of their interest & talents to projects studying late toxicity & patient reported outcomes for folks w/ anal & rectal cancers! #HollidayNonLab @MDAndersonNews

[Brian De, MD @BrianDeMD]

Love the QuadShot summary titles 😅

Thank you @QuadShotNews for featuring our work on M1 intrahepatic cholangiocarcinoma today - we're eager to validate these findings with several planned studies

@eugenekoay @ebludmir

#radiotherapy #cholangiocarcinoma @curecc

[Brian De, MD @BrianDeMD]

@HarshathGupta @MDAndersonNews Congrats and welcome to the team!